Tumor endothelial cells (ECs), under hypoxic conditions, exhibit enhanced glycolytic flux, evidenced by the upregulation of glycolytic enzymes such as hexokinase 2 (HK2), PKM2, and LDHA. Here, HK2 is linked to neoplasm.